The diagnostic algorithm included the execution of a screening test for HIT in order to detect antibodies against PF4 in patients developing confirmed thrombosis and/or thrombocytopenia between days four and sixteen after receiving a ChAdOx1 nCoV-19 vaccination. This evidence concerns the gene PF4 and Thrombocytopenia.